Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Technique
2.3.2 Market Size By Application
2.3.3 Market Size By Technology
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Regulatory & Compliance Landscape
4.1.1 Overview
4.1.2 FDA, EMA, and Regional Approvals for Tumor Profiling Tests
4.1.3 Compliance with Laboratory Standards (CLIA, ISO 15189)
4.1.4 Guidelines for Genetic Data Handling and Patient Privacy (HIPAA, GDPR)
4.1.5 Reimbursement Policies and Coverage by Health Insurance Providers
4.2 Tumor Mutation & Biomarker Metrics
4.2.1 Overview
4.2.2 Average Number of Mutations Detected Per Patient Sample
4.2.3 % Tumor Samples Tested with Actionable Biomarker Panels
4.2.4 Frequency of Rare Mutations Identified Across Cancer Types
4.2.5 % Increase in Detection of Predictive vs. Prognostic Biomarkers YoY
4.3 Patient Stratification & Therapy Guidance Metrics
4.3.1 Overview
4.3.2 % Patients Stratified for Targeted Therapy Based on Profiling Results
4.3.3 Average Time from Test Result to Therapy Initiation
4.3.4 % Patients Receiving Precision Oncology Recommendations vs. Standard Care
4.3.5 % Improvement in Treatment Personalization Using Multi-Gene Panels
4.4 Laboratory & Workflow Efficiency Metrics
4.4.1 Overview
4.4.2 Average Throughput of Tumor Profiling Tests per Lab per Month
4.4.3 % Automated vs. Manual Workflow in Sample Processing
4.4.4 Average Sample Processing Time by Technology (NGS, PCR, IHC)
4.4.5 % Labs Implementing Digital LIMS for Test Tracking & Reporting
5. Tumor Profiling Market Segmental Analysis & Forecast, By Technique, 2021 – 2032, Value (Usd Billion)
5.1 Introduction
5.2 Genomics
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Proteomics
5.4 Epigenetics
5.5 Metabolomics
6. Tumor Profiling Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (Usd Billion)
6.1 Introduction
6.2 Personalized Cancer Medicine
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Oncological Diagnostics
6.4 Research
7. Tumor Profiling Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (Usd Billion)
7.1 Introduction
7.2 Sequencing Techniques
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 qPCR
7.4 Immunohistochemistry
7.5 In Situ Hybridization
7.6 Microarray
8. Tumor Profiling Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (Usd Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.2.3 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.2.4 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.2.5 Tumor Profiling Market Size & Forecast, By Country, 2021 – 2032
8.2.5.1 USA
8.2.5.1.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.2.5.1.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.2.5.1.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.2.5.2 Canada
8.2.5.2.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.2.5.2.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.2.5.2.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3 Europe
8.3.1 Key Trends
8.3.2 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.3 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.4 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5 Tumor Profiling Market Size & Forecast, By Country, 2021 – 2032
8.3.5.1 Germany
8.3.5.1.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.1.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.1.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.2 UK
8.3.5.2.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.2.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.2.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.3 France
8.3.5.3.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.3.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.3.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.4 Italy
8.3.5.4.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.4.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.4.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.5 Spain
8.3.5.5.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.5.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.5.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.6 Russia
8.3.5.6.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.6.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.6.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.7 Poland
8.3.5.7.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.7.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.7.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.3.5.8 Rest of Europe
8.3.5.8.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.3.5.8.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.3.5.8.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.3 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.4 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5 Tumor Profiling Market Size & Forecast, By Country, 2021 – 2032
8.4.5.1 China
8.4.5.1.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.1.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.1.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5.2 India
8.4.5.2.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.2.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.2.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5.3 Japan
8.4.5.3.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.3.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.3.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5.4 South Korea
8.4.5.4.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.4.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.4.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5.5 Australia
8.4.5.5.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.5.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.5.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5.6 ASEAN Countries
8.4.5.6.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.6.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.6.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.4.5.7 Rest of Asia-Pacific
8.4.5.7.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.4.5.7.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.4.5.7.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.5 Latin America
8.5.1 Key Trends
8.5.2 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.5.3 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.5.4 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.5.5 Tumor Profiling Market Size & Forecast, By Country, 2021 – 2032
8.5.5.1 Brazil
8.5.5.1.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.5.5.1.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.5.5.1.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.5.5.2 Argentina
8.5.5.2.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.5.5.2.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.5.5.2.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.5.5.3 Mexico
8.5.5.3.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.5.5.3.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.5.5.3.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.5.5.4 Colombia
8.5.5.4.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.5.5.4.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.5.5.4.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.5.5.5 Rest of Latin America
8.5.5.5.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.5.5.5.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.5.5.5.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.3 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.4 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6.5 Tumor Profiling Market Size & Forecast, By Country, 2021 – 2032
8.6.5.1 UAE
8.6.5.1.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.5.1.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.5.1.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6.5.2 Saudi Arabia
8.6.5.2.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.5.2.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.5.2.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6.5.3 Qatar
8.6.5.3.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.5.3.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.5.3.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6.5.4 Egypt
8.6.5.4.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.5.4.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.5.4.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6.5.5 South Africa
8.6.5.5.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.5.5.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.5.5.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
8.6.5.6 Rest of Middle East & Africa
8.6.5.6.1 Tumor Profiling Market Size & Forecast, By Technique, 2021 – 2032
8.6.5.6.2 Tumor Profiling Market Size & Forecast, By Application, 2021 – 2032
8.6.5.6.3 Tumor Profiling Market Size & Forecast, By Technology, 2021 – 2032
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Key Strategies Adopted (%), By Key Players, 2024
9.2.2 Year-Wise Strategies & Development, 2021 – 2025
9.2.3 Number Of Strategies Adopted By Key Players, 2024
9.3 Market Share Analysis, 2024
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Illumina, Inc.
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 SWOT Analysis
9.6.2 QIAGEN N.V.
9.6.3 NeoGenomics Laboratories, Inc.
9.6.4 Sysmex Corporation
9.6.5 HTG Molecular Diagnostics, Inc.
9.6.6 Predictive Oncology
9.6.7 Caris Life Sciences
9.6.8 NanoString Technologies, Inc.
9.6.9 Guardant Health, Inc.
9.6.10 Foundation Medicine
9.6.11 F. Hoffmann-La Roche Ltd.
9.6.12 Thermo Fisher Scientific Inc.
9.6.13 GenScript Biotech Corporation
9.6.14 Tempus Labs
9.6.15 Hologic, Inc.
9.6.16 Exact Sciences
9.6.17 Personalis, Inc.
9.6.18 Boreal Genomics, Inc.
9.6.19 Strand Life Sciences
9.6.20 Lucence Health, Inc.
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
